Related Research Articles
Radiation therapy or radiotherapy, often abbreviated RT, RTx, or XRT, is a therapy using ionizing radiation, generally provided as part of cancer treatment to control or kill malignant cells and normally delivered by a linear accelerator. Radiation therapy may be curative in a number of types of cancer if they are localized to one area of the body. It may also be used as part of adjuvant therapy, to prevent tumor recurrence after surgery to remove a primary malignant tumor. Radiation therapy is synergistic with chemotherapy, and has been used before, during, and after chemotherapy in susceptible cancers. The subspecialty of oncology concerned with radiotherapy is called radiation oncology. A physician who practices in this subspecialty is a radiation oncologist.
Medical physics deals with the application of the concepts and methods of physics to the prevention, diagnosis and treatment of human diseases with a specific goal of improving human health and well-being. Since 2008, medical physics has been included as a health profession according to International Standard Classification of Occupation of the International Labour Organization.
A radiation oncologist is a specialist physician who uses ionizing radiation in the treatment of cancer. Radiation oncology is one of the three primary specialties, the other two being surgical and medical oncology, involved in the treatment of cancer. Radiation can be given as a curative modality, either alone or in combination with surgery and/or chemotherapy. It may also be used palliatively, to relieve symptoms in patients with incurable cancers. A radiation oncologist may also use radiation to treat some benign diseases, including benign tumors. In some countries, radiotherapy and chemotherapy are controlled by a single oncologist who is a "clinical oncologist". Radiation oncologists work closely with other physicians such as surgical oncologists, interventional radiologists, internal medicine subspecialists, and medical oncologists, as well as medical physicists and technicians as part of the multi-disciplinary cancer team. Radiation oncologists undergo four years of oncology-specific training whereas oncologists who deliver chemotherapy have two years of additional training in cancer care during fellowship after internal medicine residency in the United States.
In medicine, proton therapy, or proton radiotherapy, is a type of particle therapy that uses a beam of protons to irradiate diseased tissue, most often to treat cancer. The chief advantage of proton therapy over other types of external beam radiotherapy is that the dose of protons is deposited over a narrow range of depth; hence in minimal entry, exit, or scattered radiation dose to healthy nearby tissues.
Radiosurgery is surgery using radiation, that is, the destruction of precisely selected areas of tissue using ionizing radiation rather than excision with a blade. Like other forms of radiation therapy, it is usually used to treat cancer. Radiosurgery was originally defined by the Swedish neurosurgeon Lars Leksell as "a single high dose fraction of radiation, stereotactically directed to an intracranial region of interest".
The Armed Forces Radiobiology Research Institute (AFRRI) is an American triservice research laboratory in Bethesda, Maryland chartered by Congress in 1960 and formally established in 1961. It conducts research in the field of radiobiology and related matters which are essential to the operational and medical support of the U.S. Department of Defense (DoD) and the U.S. military services. AFRRI provides services and performs cooperative research with other federal and civilian agencies and institutions.
Louis Harold Gray FRS was an English physicist who worked mainly on the effects of radiation on biological systems. He was one of the earliest contributors of the field of radiobiology A summary of his work is given below. Amongst many other achievements, he defined a unit of radiation dosage which was later named after him as an SI unit, the gray.
Fast neutron therapy utilizes high energy neutrons typically between 50 and 70 MeV to treat cancer. Most fast neutron therapy beams are produced by reactors, cyclotrons (d+Be) and linear accelerators. Neutron therapy is currently available in Germany, Russia, South Africa and the United States. In the United States, one treatment center is operational, in Seattle, Washington. The Seattle center uses a cyclotron which produces a proton beam impinging upon a beryllium target.
Tomotherapy is a type of radiation therapy treatment machine. In tomotherapy a thin radiation beam is modulated as it rotates around the patient, while they are moved through the bore of the machine. The name comes from the use of a strip-shaped beam, so that only one “slice” of the target is exposed at any one time by the radiation. The external appearance of the system and movement of the radiation source and patient can be considered analogous to a CT scanner, which uses lower doses of radiation for imaging. Like a conventional machine used for X-ray external beam radiotherapy, a linear accelerator generates the radiation beam, but the external appearance of the machine, the patient positioning, and treatment delivery is different. Conventional linacs do not work on a slice-by-slice basis but typically have a large area beam which can also be resized and modulated.
Radiobiology is a field of clinical and basic medical sciences that involves the study of the action of ionizing radiation on living things, especially health effects of radiation. Ionizing radiation is generally harmful and potentially lethal to living things but can have health benefits in radiation therapy for the treatment of cancer and thyrotoxicosis. Its most common impact is the induction of cancer with a latent period of years or decades after exposure. High doses can cause visually dramatic radiation burns, and/or rapid fatality through acute radiation syndrome. Controlled doses are used for medical imaging and radiotherapy.
The NASA Space Radiation Laboratory (NSRL, previously called Booster Applications Facility), is a heavy ion beamline research facility; part of the Collider-Accelerator Department of Brookhaven National Laboratory, located in Upton, New York on Long Island. Its primary mission is to use ion beams (H+to Bi83+) to simulate the cosmic ray radiation fields that are more prominent beyond earth's atmosphere.
H. (Hubert) Rodney Withers was an Australian radiation biologist and physician. He made many contributions to the fields of radiobiology and clinical radiation therapy, but he is best known for his work on post-radiation tissue repair and the effects of ionizing radiation on normal tissues.
Christopher M. Nutting is a British Professor of Clinical Oncology and medical consultant, specializing in head and neck cancers, who has helped develop Intensity-Modulated Radiotherapy (IMRT), an advanced form of Radiation therapy.
Henry Harrington Janeway was an American physician and pioneer of radiation therapy.
John Martin Brown is a British scientist.
Marco Durante is an Italian physicist, recognized as an expert in the fields of radiobiology and medical physics in charged particle therapy.
Alma Clavering Howard Rolleston Ebert was a Canadian-born English radiobiologist. She was joint editor for many years of the International Journal of Radiation Biology and deputy director of Paterson Laboratories in Manchester. She made a "fundamental contribution to cell biology" in collaboration with physicist Stephen Pelc when they "were the first to ascribe a timeframe to cellular life," creating the concept of the cell cycle. Their nomenclature for the stages of cell replication is used universally and appears in every textbook of biology and pathology.
Jay Steven Loeffler was an American physician at Massachusetts General Hospital where he served as Chair of the Department of Radiation Oncology since 2000. He was the Herman and Joan Suit Professor of Radiation Oncology and Professor of Neurosurgery at Harvard Medical School.
Douglas Edward Lea was an experimental physicist working primarily in the field of radiobiology. He started working at the Cavendish Laboratory at University of Cambridge from 1931 to 1935, and in time moved from nuclear physics to focus on biology. After obtaining his PhD from Cambridge, he worked at Strangeways Laboratory from 1935 to 1946, then at the Royal College of Surgeons between 1942 and 1946.
References
- ↑ "About Us". Department of Oncology, Medical Sciences Division. University of Oxford. 19 January 2023. Retrieved 19 January 2023.
- ↑ "Why Gray?". Radiating Oncology and Biology. University of Oxford. Archived from the original on 26 February 2019. Retrieved 20 May 2016.
- ↑ "About L.H. Gray". LH Gray Memorial Trust. Retrieved 20 May 2016.
- ↑ Rockwell, Sara; Dobrucki, Iwona; Kim, Eugene; Marrison, S.; Vu, Van (1 May 2009). "Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise". Current Molecular Medicine. 9 (4): 442–458. doi:10.2174/156652409788167087. PMC 2752413 . PMID 19519402.
- ↑ Folkard, Melvyn; Vojnovic, Boris; Prise, Kevin M; Michael, Barry D (April 2002). "The application of charged-particle microbeams in radiobiology". Nuclear Instruments and Methods in Physics Research Section B: Beam Interactions with Materials and Atoms. 188 (1–4): 49–54. Bibcode:2002NIMPB.188...49F. doi:10.1016/S0168-583X(01)01007-2.
- ↑ "Gray Cancer Institute: past, present, future". MedicalPhysicsWeb. Archived from the original on 1 October 2013. Retrieved 19 January 2023.
- ↑ "Gray Cancer institute". Gray Laboratory Cancer Research Trust. 2008. Archived from the original on 3 July 2007. Retrieved 20 May 2016.